C4 Therapeutics grants new hire stock options for 162,880 shares under Nasdaq inducement rule - CCCC News | RalliesC4 Therapeutics grants new hire stock options for 162,880 shares under Nasdaq inducement rule
C
CCCC• New hire stock option grant
- C4 Therapeutics granted non-qualified stock options for 162,880 shares to one new employee on Aug. 10, 2026.
- Exercise price was set at the common stock closing price on the grant date.
- The options vest over four years: 25% on the first anniversary of the start date, then monthly in equal installments over 36 months.
CSR
•
